Dr Benjamin Young MPharm MRPharmS

Ben obtained his Pharmacy Degree with Starred First Class Honours from the University of East Anglia in Norwich, before registering as a Pharmacist with the General Pharmaceutical Council in 2009. He went on to gain a PhD in Medicinal Chemistry from the University of Bath in 2013 under the supervision of Dr Ian Eggleston, which was followed by a nine-month Postdoctoral Research Position at the University. Ben worked at St George’s Hospital in London as an Aseptic Services Pharmacist before returning to the South West to join the R&D team at Bath ASU in October 2014.

Publications

• Young B, Khan M, Chapman T, Parry R, Connolly M, Watts A. (2015) Evaluation of the physicochemical and functional stability of diluted REMSIMA® upon extended storage—A study compliant with NHS (UK) guidance. Int. J. Pharm., 496 (2): 421-31.
• Reelfs O, Young B, Radka T, Eggleston I. and Pourzand C (2014) A novel generation of photoactivatable caged-iron chelators with both antioxidant and iron chelation properties for skin photoprotection. In: European Iron Club, Verona, Italy.
• Young B (2013) Synthesis and Biological Studies on ‘Smart’ Iron Chelator Molecules. PhD Thesis, University of Bath.
• Young B, Reelfs O, Aroun A, Eggleston I and Pourzand C (2013) Light-activatable and photo-controlled caged-NIH, a promising pro-iron chelator for the topical therapy of skin cancer. American Journal of Hematology, 88: E177-E177.
• Young B, Reelfs O, Aroun A, Miri S, Hoffmann M, Pourzand C. and Eggleston I (2013) Novel light-activated caged iron chelators: targeted prodrugs for iron related-disorders. American Journal of Hematology, 88: E176-E176.
• Smith T, Young B, Denton H, Hughes D and Wagner G (2009) First small molecular inhibitors of T. brucei dolicholphosphate mannose synthase (DPMS), a validated drug target in African sleeping sickness. Bioorganic & Medicinal Chemistry Letters, 19: 1749-1752.